ClinicalTrials.Veeva

Menu

Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency

D

Dr. Hatice Dönmez

Status

Enrolling

Conditions

Primary Immunodeficiency Diseases (PID)

Treatments

Other: Tablet video watching
Other: Virtual reality video watching

Study type

Interventional

Funder types

Other

Identifiers

NCT07004803
KMU-SBF-HD-01
16-M-24 (Other Grant/Funding Number)

Details and patient eligibility

About

In this study, it is aimed to investigate the effect of virtual reality and tablet video viewing intervention on pain and fear levels and vital signs of children during peripheral venous catheter placement for intravenous immunoglobulin (IVIG) administration.

Enrollment

32 estimated patients

Sex

All

Ages

4 to 11 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Being between the ages of 4-11
  • Being followed up with the diagnosis of Primary Immunodeficiency for at least 6 months
  • To accept participation in the study voluntarily
  • No additional chronic disease other than primary immunodeficiency

Exclusion criteria

  • Organ failure is present
  • Having a mental deficiency
  • Having a disability to use VR Glasses
  • Children with fever (|>37.5 C0)
  • Children with severe dehydration

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

32 participants in 2 patient groups

Virtual reality group
Experimental group
Treatment:
Other: Virtual reality video watching
Tablet group
Active Comparator group
Treatment:
Other: Tablet video watching

Trial contacts and locations

1

Loading...

Central trial contact

Hatice Dönmez, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems